Helaina, Inc, United States
(OR23-02-24) A Randomized, Double-Blind, Controlled Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Markers of Immune Safety in Healthy Adults
Monday, July 1, 202410:12 AM – 10:24 AM CT
Disclosure information not submitted.
